Identification of miR-125a and miR-106b signature as a potential diagnostic biomarker in breast cancer tissues
- 27 March 2024
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 256, 155277
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- miR-96 and its versatile role in cancerAdvances in Cancer Biology - Metastasis, 2022
- Signaling pathways modulated by miRNAs in breast cancer angiogenesis and new therapeuticsPathology - Research and Practice, 2022
- Identification of a six‐microRNA signature as a potential diagnostic biomarker in breast cancer tissuesJournal of Clinical Laboratory Analysis, 2021
- MicroRNA: A signature for cancer progressionBiomedicine & Pharmacotherapy, 2021
- miR-106b as an emerging therapeutic target in cancerGenes & Diseases, 2021
- Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast CancerJournal of Biological Chemistry, 2015
- Prognostic value of miR-106b expression in breast cancer patientsJournal of Surgical Research, 2015
- Biogenesis, evolution and functional targets of microRNA-125aMolecular Genetics and Genomics, 2013
- Temporal Regulation of Metamorphic Processes in Drosophila by the let-7 and miR-125 Heterochronic MicroRNAsCurrent Biology, 2008
- Genomics of microRNATrends in Genetics, 2006